Renaissance Technologies
ANIX icon

Renaissance Technologies’s Anixa Biosciences ANIX Stock Holding History

Renaissance Technologies’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Sell
59,373
-1,800
-3% -$5.01K ﹤0.01% 2918
2026
Q1 		$158K Buy
61,173
+7,300
+14% +$21.6K ﹤0.01% 2956
2025
Q4 		$168K Buy
53,873
+11,109
+26% +$45.5K ﹤0.01% 2913
2025
Q3 		$141K Buy
42,764
+15,091
+55% +$47.7K ﹤0.01% 3205
2025
Q2 		$91.3K Buy
27,673
+6,200
+29% +$17.7K ﹤0.01% 3314
2025
Q1 		$61.4K Buy
21,473
+6,900
+47% +$19.7K ﹤0.01% 3269
2024
Q4 		$33.8K Buy
14,573
+3,900
+37% +$12.1K ﹤0.01% 3436
2024
Q3 		$33.6K Buy
+10,673
New +$32.8K ﹤0.01% 3387
2024
Q2 		– Sell
-68,800
Closed -$215K – 3467
2024
Q1 		$215K Buy
+68,800
New +$274K ﹤0.01% 3205
2023
Q4 		– Sell
-10,000
Closed -$33K – 3715
2023
Q3 		$33K Sell
10,000
-49,300
-83% -$173K ﹤0.01% 3460
2023
Q2 		$190K Buy
59,300
+37,998
+178% +$146K ﹤0.01% 3316
2023
Q1 		$92K Sell
21,302
-26,598
-56% -$116K ﹤0.01% 3512
2022
Q4 		$204K Sell
47,900
-9,300
-16% -$44.7K ﹤0.01% 3407
2022
Q3 		$281K Sell
57,200
-28,682
-33% -$116K ﹤0.01% 3240
2022
Q2 		$263K Sell
85,882
-138,773
-62% -$438K ﹤0.01% 3522
2022
Q1 		$616K Sell
224,655
-106,145
-32% -$311K ﹤0.01% 3047
2021
Q4 		$982K Buy
330,800
+118,600
+56% +$480K ﹤0.01% 2654
2021
Q3 		$1.01M Buy
212,200
+87,701
+70% +$396K ﹤0.01% 2543
2021
Q2 		$483K Buy
+124,499
New +$530K ﹤0.01% 2978
2020
Q2 		– Sell
-32,216
Closed -$51K – 3414
2020
Q1 		$51K Buy
+32,216
New +$94.4K ﹤0.01% 3320

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Renaissance Technologies's ANIX Position: Q2 2026 in Review

Renaissance Technologies reduced its Anixa Biosciences (ANIX) stake by 2.9% in Q2 2026, selling an estimated $5.01K and leaving 59,373 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

Renaissance Technologies first reported a position in ANIX in Q1 2020 and has held it in 20 quarters since. The position peaked at $1.01M in Q3 2021. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Renaissance Technologies held 59,373 shares of Anixa Biosciences worth $166K as of Q2 2026.
  • Renaissance Technologies sold 1,800 Anixa Biosciences shares in Q2 2026, an estimated $5.01K.
  • Anixa Biosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2918 holding.
  • Renaissance Technologies first reported a position in Anixa Biosciences in Q1 2020 and has held it in 20 quarters since.
  • Renaissance Technologies's Anixa Biosciences position peaked at $1.01M in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.